SAB Biotherapeutics Inc (NYSE: SABS) — Healthcare · Share Price, Chart & Market Data
About: SAB Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of human polyclonal immunotherapeutic antibodies to address immune system disorders and infectious diseases in the United States. Its lead product candidate is SAB-142, a potentially disease-modifying and redosable immunotherapy in clinical development for the treatment of autoimmune type 1 diabetes in Phase 2b clinical trials. The company was founded in 2014 and is headquartered in Miami Beach, Florida.
Sector: Healthcare
Industry: Biotechnology
Latest price: $3.53 (+0.28%)
SABSSAB Biotherapeutics Inc
Loading watchlist status…
Trade SABS now
SAB Biotherapeutics Inc share price
SABS price activity
Last Price
Change (24hr)
USD (%)
Volume
Volume (4w avg)
Previous Close
N/A
Last Trade
Delayed
27 Apr, 6:05 pm GMT+0
SABS price performance
-7.349%
5D
-8.312%
1M
-6.366%
YTD
97.218%
1Y
SABS price fundamentals
N/A
Shares Issued
N/A
Dividends Per Share (DPS)
N/A
Earnings Per Share (EPS)
N/A
P/E Ratio
Price market cap
Market cap
N/A
NYSE rank
N/A
Sector Rank
N/A
Delayed
27 Apr, 6:05 pm GMT+0
SABS details
SABS Market Signals